U.S. markets close in 4 hours 47 minutes
  • S&P 500

    3,611.66
    -15.25 (-0.42%)
     
  • Dow 30

    29,735.62
    -214.82 (-0.72%)
     
  • Nasdaq

    11,910.62
    -13.51 (-0.11%)
     
  • Russell 2000

    1,765.94
    -19.40 (-1.09%)
     
  • Crude Oil

    41.07
    -0.27 (-0.65%)
     
  • Gold

    1,887.00
    -0.80 (-0.04%)
     
  • Silver

    24.61
    -0.19 (-0.75%)
     
  • EUR/USD

    1.1875
    +0.0017 (+0.14%)
     
  • 10-Yr Bond

    0.8820
    -0.0240 (-2.65%)
     
  • GBP/USD

    1.3253
    +0.0056 (+0.43%)
     
  • USD/JPY

    104.2190
    -0.3510 (-0.34%)
     
  • BTC-USD

    17,271.99
    +309.34 (+1.82%)
     
  • CMC Crypto 200

    329.87
    +10.11 (+3.16%)
     
  • FTSE 100

    6,354.99
    -66.30 (-1.03%)
     
  • Nikkei 225

    26,014.62
    +107.69 (+0.42%)
     

Ebola an Issue for the Switzerland ETF

ETFtrends.com

The Ebola virus has been in the news quite a bit over the past month and although some were initially reluctant to believe it could happen because it “wasn’t in the charts,” the Ebola scare has had an impact on some corners of financial markets.

In fact, some folks in the Twittersphere derided an ETF Trends story published last month that indicated Ebola could affect the iPath DJ-UBS Cocoa TR Sub-Index ETN (NIB) and the iPath Pure Beta Cocoa ETN (CHOC) .

Of course, that criticism was ignorant to the fact that Ivory Coast, the world’s largest cocoa producer, shares a poorly monitored border with Liberia and Guinea, two countries that have been dealing with Ebola outbreaks. Interestingly, several credible news organizations have since published articles on Ebola and the potential the deadly virus has to impact global chocolate demand.

Another exchange traded product has been stung by Ebola and it is one that might catch some investors by surprise. The iShares MSCI Switzerland Capped ETF (EWL) , the largest Switzerland ETF, is off 4% since we published our piece on Ebola potentially damaging African cocoa crops. This is not a coincidence, nor is it coincidental that chocolate lovers may be paying more for Nestle Crunch and KitKat bars these days.

Speaking of Nestle (NSRGY), the world’s largest publicly traded food maker, “bearish (options) contracts on the maker of Baby Ruth bars cost the most relative to bullish ones in more than a year” while “hedge funds have raised bets that cocoa will soar even more after it completed the longest series of monthly gains in 12 years,” reports Sofia Horta e Costa for Bloomberg.

Those are key points to the $1.1 billion EWL because the ETF devotes nearly 17.1% of its weight to Nestle, almost 230 basis points more than is allocated to Novartis (NVS), EWL’s second-largest holding. [Big Investors Like Switzerland ETFs]

To be fair, it is not just Ebola fears and the impact on Nestle that have recently weighed on EWL. European equities, Ebola or not, have been weak. Of the 106 ETFs that hit new 52-week lows on Wednesday, 15 were Europe funds. EWL was not one of them. [Swiss ETFs Steadt as Usual]

Whether it is Ebola-related or not, there is no denying that exposure to Swiss equities, often prized by conservative global investors, has belied that conservative reputation. Since Sept. 19, the Vanguard FTSE Europe ETF (VGK) , an ETF that features Nestle as its second-largest equity holding and Switzerland as its third-largest country weight at 13.7%, is off 5.8%. The WisdomTree Europe Hedged Equity Fund (HEDJ) , which has no exposure to Swiss stocks, is off 4.6% over the same period.

iShares MSCI Switzerland Capped ETF

ewl
ewl